Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Beuzeboc

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
Human Vaccines & Immunotherapeutics|October 12, 2023
Vaccination against HPV: Easier said than done?Henri-Corto Stoeklé, Sakina Sekkate, Jean-Marc Ayoubi, et al.
Annals of Surgery|October 25, 2008
Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovaryGilles Palenzuela, Elvira Martin, Anne Meunier, et al.
La Revue Du Praticien|April 16, 2019
[Nausea and vomiting induced by chemotherapy]Florian Scotté, Mathilde Chastenet, Pauline Leroy, et al.
Bulletin Du Cancer|March 21, 2007
[Trastuzumab (Herceptin) and breast cancer: mechanisms of resistance]Véronique Dieras, Anne Vincent-Salomon, Armelle Degeorges, et al.
La Revue Du Praticien|April 16, 2019
[Supportive care in oncology: definition, organization, limits]Florian Scotté, Mathilde Chastenet, Pauline Leroy, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2020
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic reviewRaffaele Ratta, Annalisa Guida, Florian Scotté, et al.
Bulletin Du Cancer|February 7, 2004
[Targeting epidermal growth factor receptor in cancer of the breast]Véronique Diéras, Jean-Yves Pierga, Anne Vincent-Salomon, et al.
The Journal of Urology|June 11, 2003
Primitive neuroectodermal tumor of the prostateMichaël Peyromaure, Annick Vieillefond, Eric Boucher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Severe docetaxel overdose induced by pharmacokinetic interaction with dronedaroneDominique Vodovar, Nicolas Mongardon, Laurence Moachon, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric StudyElodie Dang, Alexandre Vallée, Coralie Lepage-Seydoux, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
Human Vaccines & Immunotherapeutics|October 12, 2023
Vaccination against HPV: Easier said than done?Henri-Corto Stoeklé, Sakina Sekkate, Jean-Marc Ayoubi, et al.
Annals of Surgery|October 25, 2008
Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovaryGilles Palenzuela, Elvira Martin, Anne Meunier, et al.
La Revue Du Praticien|April 16, 2019
[Nausea and vomiting induced by chemotherapy]Florian Scotté, Mathilde Chastenet, Pauline Leroy, et al.
Bulletin Du Cancer|March 21, 2007
[Trastuzumab (Herceptin) and breast cancer: mechanisms of resistance]Véronique Dieras, Anne Vincent-Salomon, Armelle Degeorges, et al.
La Revue Du Praticien|April 16, 2019
[Supportive care in oncology: definition, organization, limits]Florian Scotté, Mathilde Chastenet, Pauline Leroy, et al.
Prostate Cancer and Prostatic Diseases|May 6, 2020
PARP inhibitors as a new therapeutic option in metastatic prostate cancer: a systematic reviewRaffaele Ratta, Annalisa Guida, Florian Scotté, et al.
Bulletin Du Cancer|February 7, 2004
[Targeting epidermal growth factor receptor in cancer of the breast]Véronique Diéras, Jean-Yves Pierga, Anne Vincent-Salomon, et al.
The Journal of Urology|June 11, 2003
Primitive neuroectodermal tumor of the prostateMichaël Peyromaure, Annick Vieillefond, Eric Boucher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Severe docetaxel overdose induced by pharmacokinetic interaction with dronedaroneDominique Vodovar, Nicolas Mongardon, Laurence Moachon, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Clinical Benefit of Pembrolizumab in Advanced Urothelial Cancer Patients in Real-Life Setting: An Efficacy and Safety Monocentric StudyElodie Dang, Alexandre Vallée, Coralie Lepage-Seydoux, et al.
Pageof 13